Stay updated on Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page.

Latest updates to the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe NiTraSarc study page now shows a 403 Forbidden error with a minimal header and a Home link; the detailed study content is no longer visible, leaving an error screen as the primary content.SummaryDifference19%

- Check35 days agoChange DetectedRevision: v3.7.0 is now shown on the page, replacing v3.6.6. This indicates a software/content update to the Study Details page without altering the underlying study data.SummaryDifference0.1%

- Check49 days agoChange DetectedFooter revision label updated from Revision: v3.6.5 to Revision: v3.6.6, representing a minor page update. It does not indicate changes to the study content or data.SummaryDifference0.1%

- Check56 days agoChange DetectedAn entry '2017 ( U.S. NIH Grant/Contract )' was added to the study's identifiers/funding area, appearing alongside the GISG and EudraCT numbers. This enriches the record with NIH funding attribution for that year.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a platform version update on the page.SummaryDifference0.0%

Stay in the know with updates to Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page.